| Home > Publications Database > Connective tissue growth factor regulates interneuron survival and information processing in the olfactory bulb. > print |
| 001 | 137225 | ||
| 005 | 20240321220219.0 | ||
| 024 | 7 | _ | |a 10.1016/j.neuron.2013.07.011 |2 doi |
| 024 | 7 | _ | |a pmid:23993699 |2 pmid |
| 024 | 7 | _ | |a 0896-6273 |2 ISSN |
| 024 | 7 | _ | |a 1097-4199 |2 ISSN |
| 024 | 7 | _ | |a altmetric:1718647 |2 altmetric |
| 037 | _ | _ | |a DZNE-2020-03547 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Khodosevich, Konstantin |0 P:(DE-HGF)0 |b 0 |
| 245 | _ | _ | |a Connective tissue growth factor regulates interneuron survival and information processing in the olfactory bulb. |
| 260 | _ | _ | |a New York, NY |c 2013 |b Elsevier |
| 264 | _ | 1 | |3 print |2 Crossref |b Elsevier BV |c 2013-09-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1710769665_18974 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Neurogenesis underlies plastic changes in defined neuronal circuits in the postnatal and adult brain. Here we identify connective tissue growth factor (CTGF) as a critical factor in the mouse olfactory bulb (OB) in determining the efficiency of incorporation of postnatally born inhibitory neurons, thus gating the output of glomeruli, the first relay station of olfactory processing in the brain. In the OB, CTGF expression was restricted to prenatally born external tufted cells. CTGF enhanced the proapoptotic activity of glial-derived TGF-β2, decreasing the survival of periglomerular inhibitory neurons. Changes in CTGF expression levels in the OB led to modifications in local neuronal circuitry and olfactory behaviors. We show that the odorant-specific recruitment of distinct glomeruli resulted in enhanced local CTGF expression levels in the activated glomeruli. Collectively our data reveal a molecular mechanism controlling the survival of defined postnatally born neurons, thus adapting neuronal integration to the sensory experiences. |
| 536 | _ | _ | |a 341 - Molecular Signaling (POF3-341) |0 G:(DE-HGF)POF3-341 |c POF3-341 |f POF III |x 0 |
| 542 | _ | _ | |i 2013-09-01 |2 Crossref |u https://www.elsevier.com/tdm/userlicense/1.0/ |
| 542 | _ | _ | |i 2014-09-18 |2 Crossref |u https://www.elsevier.com/open-access/userlicense/1.0/ |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a Luminescent Proteins |2 NLM Chemicals |
| 650 | _ | 7 | |a MicroRNAs |2 NLM Chemicals |
| 650 | _ | 7 | |a Nerve Tissue Proteins |2 NLM Chemicals |
| 650 | _ | 7 | |a Olfr16 protein, mouse |2 NLM Chemicals |
| 650 | _ | 7 | |a RNA, Small Interfering |2 NLM Chemicals |
| 650 | _ | 7 | |a Receptors, Odorant |2 NLM Chemicals |
| 650 | _ | 7 | |a Receptors, Transforming Growth Factor beta |2 NLM Chemicals |
| 650 | _ | 7 | |a tau Proteins |2 NLM Chemicals |
| 650 | _ | 7 | |a Connective Tissue Growth Factor |0 139568-91-5 |2 NLM Chemicals |
| 650 | _ | 7 | |a Protein-Serine-Threonine Kinases |0 EC 2.7.11.1 |2 NLM Chemicals |
| 650 | _ | 7 | |a Receptor, Transforming Growth Factor-beta Type II |0 EC 2.7.11.30 |2 NLM Chemicals |
| 650 | _ | 7 | |a Bromodeoxyuridine |0 G34N38R2N1 |2 NLM Chemicals |
| 650 | _ | 7 | |a biocytin |0 G6D6147J22 |2 NLM Chemicals |
| 650 | _ | 7 | |a Lysine |0 K3Z4F929H6 |2 NLM Chemicals |
| 650 | _ | 2 | |a Analysis of Variance |2 MeSH |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a Animals, Newborn |2 MeSH |
| 650 | _ | 2 | |a Bromodeoxyuridine: metabolism |2 MeSH |
| 650 | _ | 2 | |a Cell Line, Transformed |2 MeSH |
| 650 | _ | 2 | |a Cell Survival: genetics |2 MeSH |
| 650 | _ | 2 | |a Connective Tissue Growth Factor: genetics |2 MeSH |
| 650 | _ | 2 | |a Connective Tissue Growth Factor: metabolism |2 MeSH |
| 650 | _ | 2 | |a Discrimination, Psychological: physiology |2 MeSH |
| 650 | _ | 2 | |a Female |2 MeSH |
| 650 | _ | 2 | |a Gene Expression Regulation: genetics |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Interneurons: physiology |2 MeSH |
| 650 | _ | 2 | |a Luminescent Proteins: genetics |2 MeSH |
| 650 | _ | 2 | |a Luminescent Proteins: metabolism |2 MeSH |
| 650 | _ | 2 | |a Lysine: analogs & derivatives |2 MeSH |
| 650 | _ | 2 | |a Lysine: metabolism |2 MeSH |
| 650 | _ | 2 | |a Male |2 MeSH |
| 650 | _ | 2 | |a Memory, Long-Term: physiology |2 MeSH |
| 650 | _ | 2 | |a Mice |2 MeSH |
| 650 | _ | 2 | |a Mice, Inbred C57BL |2 MeSH |
| 650 | _ | 2 | |a Mice, Transgenic |2 MeSH |
| 650 | _ | 2 | |a MicroRNAs: genetics |2 MeSH |
| 650 | _ | 2 | |a MicroRNAs: metabolism |2 MeSH |
| 650 | _ | 2 | |a Nerve Tissue Proteins: genetics |2 MeSH |
| 650 | _ | 2 | |a Nerve Tissue Proteins: metabolism |2 MeSH |
| 650 | _ | 2 | |a Odorants |2 MeSH |
| 650 | _ | 2 | |a Olfactory Bulb: cytology |2 MeSH |
| 650 | _ | 2 | |a Olfactory Bulb: physiology |2 MeSH |
| 650 | _ | 2 | |a Organ Culture Techniques |2 MeSH |
| 650 | _ | 2 | |a Protein-Serine-Threonine Kinases: genetics |2 MeSH |
| 650 | _ | 2 | |a RNA, Small Interfering: genetics |2 MeSH |
| 650 | _ | 2 | |a RNA, Small Interfering: metabolism |2 MeSH |
| 650 | _ | 2 | |a Receptor, Transforming Growth Factor-beta Type II |2 MeSH |
| 650 | _ | 2 | |a Receptors, Odorant: genetics |2 MeSH |
| 650 | _ | 2 | |a Receptors, Odorant: metabolism |2 MeSH |
| 650 | _ | 2 | |a Receptors, Transforming Growth Factor beta: genetics |2 MeSH |
| 650 | _ | 2 | |a Sensory Thresholds: physiology |2 MeSH |
| 650 | _ | 2 | |a Smell: genetics |2 MeSH |
| 650 | _ | 2 | |a Synaptic Potentials: genetics |2 MeSH |
| 650 | _ | 2 | |a Transfection |2 MeSH |
| 650 | _ | 2 | |a tau Proteins: genetics |2 MeSH |
| 700 | 1 | _ | |a Lazarini, Françoise |0 P:(DE-HGF)0 |b 1 |
| 700 | 1 | _ | |a Engelhardt, Jakob |0 P:(DE-2719)2810460 |b 2 |u dzne |
| 700 | 1 | _ | |a Kaneko, Hiroshi |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Lledo, Pierre-Marie |0 P:(DE-HGF)0 |b 4 |
| 700 | 1 | _ | |a Monyer, Hannah |0 P:(DE-HGF)0 |b 5 |e Corresponding author |
| 773 | 1 | 8 | |a 10.1016/j.neuron.2013.07.011 |b : Elsevier BV, 2013-09-01 |n 6 |p 1136-1151 |3 journal-article |2 Crossref |t Neuron |v 79 |y 2013 |x 0896-6273 |
| 773 | _ | _ | |a 10.1016/j.neuron.2013.07.011 |g Vol. 79, no. 6, p. 1136 - 1151 |0 PERI:(DE-600)2001944-0 |n 6 |q 79:6<1136 - 1151 |p 1136-1151 |t Neuron |v 79 |y 2013 |x 0896-6273 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/137225/files/DZNE-2020-03547_Restricted.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/137225/files/DZNE-2020-03547_Restricted.pdf?subformat=pdfa |x pdfa |
| 909 | C | O | |p VDB |o oai:pub.dzne.de:137225 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2810460 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-341 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Molecular Signaling |x 0 |
| 914 | 1 | _ | |y 2013 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NEURON : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b NEURON : 2017 |
| 920 | 1 | _ | |0 I:(DE-2719)1013023 |k AG Engelhardt |l Synaptic Signalling and Neurodegeneration |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1013023 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|